Intrabio – Clinical Trial Expansion

On February 16, 2021, the A-T Children’s Project sent the below email to A-T families in the United States announcing that the pharmaceutical company IntraBio has expanded their clinical trial to test N-Acetyl-L-Leucine in A-T patients, and we will be helping with recruitment.  Dear A-T Parents, Last year, we let you know that the A-T … Read More

A Biomarker to Track Brain Cell Death in A-T Kids

Hi everyone, I hope you and your families are continuing to stay safe during the pandemic. Over the past year, you’ve heard me talk a lot about testing an approach called antisense oligonucleotide (ASO) gene therapy in a little girl with   A-T. She has continued to receive regular injections, and we’re grateful that we haven’t … Read More